‌

US Patent 8765954 1,8-naphthyridine compounds for the treatment of cancer

Patent 8765954 was granted and assigned to Sunesis Pharmaceuticals Inc on July, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

‌

Sunesis Pharmaceuticals Inc

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8765954

Patent Inventor Names

Marc J. Evanchik0

Daniel C. Adelman0

Jeffrey A. Silverman0

Jeffrey William Jacobs0

Anantha Sudhakar0

Date of Patent

July 1, 2014

Patent Application Number

13360558

Date Filed

January 27, 2012

Patent Primary Examiner

‌

David K O Dell

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8765954 1,8-naphthyridine compounds for the treatment of cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API